A research team has uncovered a new mechanism involving astrocytes for treating Alzheimer’s disease (AD) and proposed a novel therapeutic target.
Researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham health care system, have published results showing that among older adults…
A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer’s, new research shows.
Dietary compound increases longevity and protects against Alzheimer’s disease in experimental models
Researchers from the Color and Food Quality group at the Faculty of Pharmacy (University of Seville), in collaboration with Dr. Marina Ezcurra’s group at the…
The safety and effectiveness of donanemab—an Alzheimer’s drug recently approved by the US Food & Drug Administration (FDA)—is called into question in an investigation published…
Worldwide, at least 50 million people are believed to be living with a form of dementia. Alzheimer’s disease is the most common type of dementia.…
A team of public health researchers at Ningxia Medical University, in China, has found, via analysis of health record data, that some regular coffee drinkers…
Two new drugs, the first capable of slowing down the debilitating progression of Alzheimer’s disease, have become embroiled in one of the biggest medical controversies…
A new study helps explain why having ApoE4—the gene variant most closely linked to Alzheimer’s disease—increases the risk of neurodegeneration and white matter damage.
Creative expression interventions, such as fictional storytelling, could improve the lives of people living with dementia, according to research from the University of Surrey.